Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT00256750
Show Display Options
Rank Status Study
1 Completed
Has Results
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Conditions: Kidney Transplantation;   Chronic Kidney Failure
Interventions: Drug: Cyclosporine (CsA);   Drug: Belatacept LI (less intensive);   Drug: Belatacept MI (more intensive)

Study has passed its completion date and status has not been verified in more than two years.